A real-world pharmacovigilance analysis of acute renal failure associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS)
The widespread use of sacubitril/valsartan has raised safety concerns, particularly regarding acute renal failure. Our study, leveraging real-world FAERS data, systematically analyzed this association, providing new evidence on acute renal failure risks.
Authors
- Qingmao Luo
- Jianping Lai (ORCID: https://orcid.org/0000-0002-3217-692X)
- Wenyan Yi
- Shiyu Wang (ORCID: https://orcid.org/0009-0009-0028-2531)
- Ying‐Yu Lai
- Jia-Hao Chen (ORCID: https://orcid.org/0009-0005-8699-9373)
Institutions
- Hezhou University (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1371/journal.pone.0334402
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00